4Wang YF, Ouyang Q,Hu RW. Progression of inflammatory bowel disease in China[J]. J Dig Dis,2010,11(2):76-82.
5Cosnes J,Gower RC, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases [J]. Gastroenterology, 2011,140(6):1785-1794.
6Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treat- ment of fistulas in patients with Crohn's disease [J]. N Engl J Med, 1999, 340(5):1398.
7D' Haens G, Baert F, van Assche G, et al. Early combined immu-nosuppression or conventional management in patients with new- ly diagnosed Crohn's disease: an open randomised trial[J]. Lan- cet, 2008, 371(9613): 660-667.
8Gao X, Yang RP, Chen MH, et al. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease [J]. Scand J Gastroenterol, 2012, 47(10): 1181-1191.
9Brouquet A, Blanc B, Bretagnol F, et al. Surgery for intestinal Crohn's disease recurrence[J]. Surgery, 2010,148(5): 936-946.
10Michelassi F,Taschieri A, Tonelli F,et al. Risk factors for in- tra-abdominal septic complications after a first ileocecal resec- tion for Crohn's disease: a multivariate analysis in 161 consecu- tive patients [ J ]. Dis Colon Rectum ,2007,50(3):331-336.
